Related Experiment Videos

Hereditary neuropathy with liability to pressure palsies with a small deletion interrupting the PMP22 gene

R A C van de Wetering1, A A W M Gabreëls-Festen, V Timmerman

  • 1Institute of Neurology, University Medical Centre Nijmegen, Nijmegen, The Netherlands

Neuromuscular Disorders : NMD
|September 5, 2002
PubMed

Insights

Hereditary neuropathy with liability to pressure palsies (HNPP) can result from a partial deletion of the PMP22 gene. This study identifies a novel small deletion in the PMP22 gene in an HNPP family, differing from the common large deletion.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Hereditary neuropathy with liability to pressure palsies (HNPP) is a genetic disorder affecting peripheral nerves.
  • It is typically caused by a large deletion on chromosome 17p11.2-12, which includes the Peripheral Myelin Protein 22 (PMP22) gene.
  • PMP22 is crucial for the formation and maintenance of myelin sheaths in peripheral nerves.

Observation:

  • A family with HNPP was identified who did not possess the common 1.5 Mb deletion on chromosome 17p11.2-12.
  • Genetic analysis revealed a distinct, smaller deletion within this family.
  • This novel deletion specifically targets the 3' region of the PMP22 gene.

Findings:

  • The identified deletion results in a partial deletion of one copy of the PMP22 gene.
  • This partial deletion leads to a deficiency in PMP22, consistent with the PMP22 deficiency observed in typical HNPP cases.
  • This finding expands the known genetic mechanisms underlying HNPP.

Implications:

  • This discovery broadens the understanding of genetic mutations causing HNPP.
  • It highlights the importance of PMP22 gene dosage in peripheral nerve health.
  • This may lead to improved genetic diagnostics and counseling for families affected by HNPP.

Related Concept Videos